What Does T Stage Mean in Cancer?

In the TNM staging system, T describes the primary tumor. NCI defines the T category as the size, the local extent, or both, of the main tumor. Higher numbers mean a larger tumor or deeper growth into nearby tissue.

T is not the stage. It is one of three inputs. N covers the regional lymph nodes and M covers spread to distant parts of the body. A stage number like II or III comes from combining all three.

A handful of T values carry the same meaning no matter which cancer you have.

• TX means the primary tumor could not be measured.
• T0 means no primary tumor was found.
• Tis means carcinoma in situ, a growth that has not broken through into the tissue below.
• T1 through T4 mark increasing size or increasing invasion.

That is where the shared vocabulary ends. The moment you ask what a T2 actually is, the answer depends entirely on which organ the cancer started in.

Compare the AJCC definitions that NCI publishes for three common cancers. The T numbers look identical. They measure different things.

Breast cancer runs on millimeters. T1mi is 1 mm or less. T1a is over 1 mm up to 5 mm. T1b is over 5 mm up to 10 mm. T1c is over 10 mm up to 20 mm. T2 is over 20 mm up to 50 mm. T3 is over 50 mm. T4 leaves size behind entirely: T4a is extension to the chest wall, T4b involves skin ulceration, swelling, or satellite nodules on the same side, T4c is both together, and T4d is inflammatory carcinoma.

Lung cancer runs on centimeters. T1a is 1 cm or less. T1b is over 1 cm up to 2 cm. T1c is over 2 cm up to 3 cm. T2a is over 3 cm up to 4 cm, and T2b is over 4 cm up to 5 cm. T3 covers tumors over 5 cm up to 7 cm, or any tumor invading the parietal pleura, chest wall, phrenic nerve, or parietal pericardium. T4 covers tumors over 7 cm, or invasion of the diaphragm, mediastinum, heart, great vessels, trachea, recurrent laryngeal nerve, esophagus, a vertebral body, or the carina.

Colon cancer ignores size and counts layers. Tis is carcinoma in situ or intramucosal carcinoma, involving the lamina propria without passing through the muscularis mucosae. T1 invades the submucosa. T2 invades the muscularis propria, the thick muscle coat. T3 goes through the muscularis propria into the surrounding pericolorectal tissue. T4a breaks through the visceral peritoneum, the outer lining. T4b directly invades or sticks to an adjacent organ or structure.

A 3 cm colon tumor confined to the muscle wall is T2. A 3 cm lung tumor is T1c. A 3 cm breast tumor is T2. Nothing is inconsistent here. The scales were built separately, from separate outcome data.

A prefix before the T tells you where the information came from, and it matters more than most people expect.

• cT is clinical. ACS defines clinical stage as an estimate based on physical exam, imaging such as CT or x-ray, endoscopy, and any biopsies done before treatment starts.
• pT is pathological. It uses everything from before surgery plus what the surgeon and pathologist find in the removed specimen. It is assigned when surgery is the first treatment.
• yT marks restaging after neoadjuvant therapy, meaning treatment given before surgery. A tumor treated with chemotherapy first is scored as ycT or ypT.

So a cT2 based on a CT scan and a pT2 based on a measured specimen are not equally certain. If your report shows a c prefix, the measurement came from a picture, not from tissue.

ACS also notes what happens if cancer returns or spreads later. The new classification is added to the original stage; it does not replace it. That is why your record may keep listing the stage from diagnosis years afterward.

Two people can both be T2 and face very different treatment, because N and M differ.

Node counting has its own rules. For colon and rectal cancer, NCI reports that AJCC and an NCI-sponsored panel recommended that at least 12 lymph nodes be examined before calling the nodes negative. If only 4 nodes were removed, an N0 result is on thinner ice than the label suggests. That is a fair question to raise about your own pathology report.

M is the sharpest divider. NCI defines M0 as no spread to distant parts of the body and M1 as spread present. M1 usually reshapes the whole treatment approach, no matter how small the T.

The T can change legitimately, and knowing why prevents alarm.

• Imaging measurement is estimated. A pathologist measuring the removed tumor may find a different size than the radiologist did.
• Neoadjuvant treatment shrinks tumors, so a ypT can be lower than the original cT.
• A tumor that invades one more structure jumps categories even if it did not grow much in size. In lung cancer, invading the carina moves a tumor to T4 regardless of centimeters.

• Is my T clinical or pathological, and which test produced it?
• What exact measurement or structure led to that category?
• How many lymph nodes were examined, and how many contained cancer?
• Is the M status settled, or is imaging still pending?
• If I get treatment before surgery, when will the T be reassessed?

Bring the report itself. The T category is usually printed in a synoptic summary near the end of the pathology report, next to N and M.

For related reading, see Cancer Staging, Pathology Reports, and Imaging Tests.

• National Cancer Institute — Cancer Staging
• National Cancer Institute — Breast Cancer Treatment (PDQ), Health Professional Version
• National Cancer Institute — Non-Small Cell Lung Cancer Treatment (PDQ), Health Professional Version
• National Cancer Institute — Colon Cancer Treatment (PDQ), Health Professional Version
• American Cancer Society — Cancer Staging